Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain
Yoann Sottejeau(Inserm), Jean‐Charles Lambert(Inserm), Florie Demiaute(Inserm), Guy Lippens(Centre National de la Recherche Scientifique), Philippe Amouyel(Institut Pasteur de Lille), Isabelle Landrieu(Centre National de la Recherche Scientifique), Bart Dermaut(Inserm), Harmony Alves dos Alves(Inserm), Amandine Flaig(Inserm), Peter Davies(Albert Einstein College of Medicine), François‐Xavier Cantrelle(Centre National de la Recherche Scientifique), Pierre Dourlen(Inserm), Julien Chapuis(Inserm), Tiago Mendes(Inserm), Jocelyn Laporte(Centre National de la Recherche Scientifique), Alexis Bretteville(Inserm), Nicolas Malmanche(Universidade do Porto), Charlotte Delay(Inserm)
Cited by 98
Related Papers
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k